The Discounted Cash Flow (DCF) valuation of Fredun Pharmaceuticals Ltd (539730.BO) is 475.56 INR. With the latest stock price at 844.25 INR, the upside of Fredun Pharmaceuticals Ltd based on DCF is -43.7%.
Based on the latest price of 844.25 INR and our DCF valuation, Fredun Pharmaceuticals Ltd (539730.BO) is a sell. selling 539730.BO stocks now will result in a potential gain of 43.7%.
| Range | Selected | |
| WACC / Discount Rate | 13.6% - 17.5% | 15.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 323.33 - 711.25 | 475.56 |
| Upside | -61.7% - -15.8% | -43.7% |